drugset / Trial / NCT01634191

Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults

NCT01634191

Phase 1 Completed 36 enrolled Amgen
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to evaluate the effects of age and sex on the pharmacokinetics and safety of a single oral dose of 30 mg apremilast in healthy adults.

Timeline

Start
2012-02-01
Primary completion
2012-03-01
Completion
2012-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Apremilast Small molecule 30 mg Oral

Indications

No indication recorded.